1. Introduction {#sec1-molecules-21-00130}
===============

Plant pathogenic fungi remain a main cause of plant diseases, which can infect any tissue of a plant and cause severe yield agricultural product losses \[[@B1-molecules-21-00130],[@B2-molecules-21-00130],[@B3-molecules-21-00130]\]. Moreover, the presence of some phyto-fungal mycotoxins can be harmful to animal and human health \[[@B4-molecules-21-00130]\]. *Colletotrichum lagenarium* and *Botrytis cinerea* are the most common plant pathogenic fungi, and can cause cross-infections between diseased and healthy plants \[[@B5-molecules-21-00130],[@B6-molecules-21-00130],[@B7-molecules-21-00130]\]. In addition, they cause significant reductions of crop yield and quality \[[@B8-molecules-21-00130]\]. Traditional chemical fungicides play an important role in killing or controlling target fungi directly, but sometimes cause adverse effects to the environment and food, and often create fungicide resistance \[[@B9-molecules-21-00130]\]. Therefore, it is urgent to develop novel and effective fungicidal agents to protect plants.

The α-methylene-γ-butyrolactone ring can be found as a key substructural unit in many sesquiterpenoids ([Figure 1](#molecules-21-00130-f001){ref-type="fig"}). It exhibits multiple biological properties, including antibacterial, cytotoxic, antiinflammatory, antioxidant, allergenic and antimicrobial activity \[[@B10-molecules-21-00130],[@B11-molecules-21-00130],[@B12-molecules-21-00130],[@B13-molecules-21-00130],[@B14-molecules-21-00130],[@B15-molecules-21-00130],[@B16-molecules-21-00130]\]. In our previous research, we found that carabrone (which is isolated from fruits of *Carpesium macrocephalum*) and its derivatives exhibited potent antifungal activity against *C. lagenarium*, and the structure-activity relationship (SAR) analysis of these compounds indicated that the α-methylene-γ-butyrolactone ring was a major biofunctional group in the carabrone structure \[[@B17-molecules-21-00130],[@B18-molecules-21-00130],[@B19-molecules-21-00130],[@B20-molecules-21-00130]\]. Besides, γ-monosubstituted compounds of the α-methylene-γ-lactone ring have also been synthesized, and we concluded that aromatic substituents directly fused to the γ-position improved the potency more effectively than alkyl groups. Meanwhile, the cytotoxicity was tested to ensure the selectivity of the fungicidal effects \[[@B21-molecules-21-00130]\].

![Some representative sesquiterpenoid structures.](molecules-21-00130-g001){#molecules-21-00130-f001}

It is virtually and economically impossible to develop and screen candidates with fungicidal activity from among numberless compounds. The development of new quantitative structure-activity relationship (QSAR) methods, with simple molecular indexes, is a promising shortcut to resolve the cost and time issues \[[@B22-molecules-21-00130]\]. The QSAR method enables the calculation of numerous quantitative descriptors on the basis of molecular structural information and is very useful to optimize important aspects such as fungicidal activity or toxicity. Meanwhile, QSAR is useful in provide further guidance for the design and development of potential new fungicides \[[@B23-molecules-21-00130],[@B24-molecules-21-00130]\].

In order to obtain novel natural product-based fungicides, two series of derivatives based on γ-monosubstituted α-methylene-γ-butyrolactone rings were synthesized on the basis of their molecular similarity. The fungicidal activities of these compounds against *C. lagenarium* and *B. cinerea* were investigated and their structures were characterized by ^1^H-NMR, ^13^C-NMR, and HRMS spectrometric analysis. Meanwhile, the cytotoxicity was tested to ensure selectivity of the antifungal effects. Moreover, a QSAR study was also performed on all of the derivatives using the Gaussian and CODESSA software packages, which can correlate their structural features with their fungicidal activity.

2. Results and Discussion {#sec2-molecules-21-00130}
=========================

2.1. Synthesis {#sec2dot1-molecules-21-00130}
--------------

Three kinds of intermediate compounds **4**--**6** were prepared by the cyclization of γ-hydroxy-α-methylene esters, which were obtained under mild aqueous reaction conditions through indium-mediated Barbier allyl addition to aldehydes \[[@B25-molecules-21-00130]\]. In order to investigate the structure-activity relationships, different acids were reacted with the three kinds of intermediate compounds to obtain the corresponding ester compounds. Then, six new ether compounds were obtained by reacting with them with brominated alkanes. The structures of all the derivatives were characterized by ^1^H-NMR, ^13^C-NMR and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS). The synthetic routes are shown in [Scheme 1](#molecules-21-00130-f005){ref-type="scheme"}.

![Synthetic route of the title compounds.](molecules-21-00130-g005){#molecules-21-00130-f005}

2.2. Fungicidal Activity and Structure-Activity Relationships (SAR) {#sec2dot2-molecules-21-00130}
-------------------------------------------------------------------

### 2.2.1. Fungicidal Activity of the Title Compounds against *C. lagenarium* {#sec2dot2dot1-molecules-21-00130}

The results of the fungicidal activity against *C. lagenarium* are summarized in [Table 1](#molecules-21-00130-t001){ref-type="table"}, from which it can be seen that the halogen atom-containing derivatives exhibited significant fungicidal activity against this species. The following three main SARs were obtained: first, the introduction of the electron-withdrawing groups Cl, Br, and CN onto the benzene ring dramatically increased the potency. Compounds **4a--f**, **5a--e**, and **6a--e** (IC~50~ \< 18 μM) exhibited fungicidal activity approximately ten to twenty fold higher than the intermediate compounds **4--6**, respectively. It was notable that the IC~50~ values of **6a**,**d** were approximately two fold lower than those of chlorothalonil, a commercial fungicide. Meanwhile, the electron-donating groups CH~3~ and CH~3~O introduced onto the benzene ring to give **4j--o**, **5h--l** and **6g--l** (IC~50~ \> 126 μM) greatly weakened the potency, which was similar to that of the fatty acid derivatives **4p**, **5m** and **6m**. It can be concluded that the electronic effect of the substituent on the benzene ring is important for the fungicidal activity of α-methylene-γ-butyrolactone groups. Second, intermediate compound **6** was found to have higher activity than the corresponding intermediate compounds **4** and **5**. Meanwhile, *meta*-substitution on the benzene ring (compounds **6a--p**) was found to improve the potency significantly compared with the corresponding *ortho*- and *para*-substitution patterns (compounds **4a--r** and **5a--r**). This result suggests that the steric effect should be considered and substitution patterns on the benzene ring have an important influence on the fungicidal activity. Third, all of the synthesized ether compounds exhibited lower fungicidal activity against *C. lagenarium* than the corresponding ester compounds. It was notable that the cinnamic acid and fumalic acid derivatives **4q--r**, **5n** and **6n** containing an unsaturated bond showed higher fungicidal activity against *C. lagenarium*.

molecules-21-00130-t001_Table 1

###### 

*In vitro* fungicidal activity of compounds against *C. lagenarium* and *B. cinerea*.

  Compd.   *C. lagenarium*   *B. cinerea*   Compd.   *C. lagenarium*          *B. cinerea*            
  -------- ----------------- -------------- -------- ------------------------ -------------- -------- --------
  **4a**   13.96             −1.145         29.81    **5k**                   291.95         −2.465   306.85
  **4b**   8.99              −0.954         22.13    **5l**                   283.99         −2.453   303.36
  **4c**   12.74             −1.105         27.31    **5m**                   173.74         −2.240   205.50
  **4d**   15.62             −1.194         24.09    **5n**                   10.27          −1.012   20.57
  **4e**   8.76              −0.943         30.24    **5o**                   413.72         −2.617   456.91
  **4f**   14.38             −1.158         23.01    **5p**                   499.33         −2.698   524.54
  **4g**   52.87             −1.723         60.61    **5q**                   428.93         −2.632   446.08
  **4h**   65.63             −1.817         77.00    **5r**                   519.42         −2.716   548.63
  **4i**   95.38             −1.979         111.77   **6a**                   7.68           −0.885   23.32
  **4j**   192.44            −2.284         198.67   **6b**                   9.24           −0.966   29.08
  **4k**   177.96            −2.250         193.28   **6c**                   10.27          −1.012   27.45
  **4l**   188.93            −2.276         209.12   **6d**                   8.17           −0.912   25.99
  **4m**   238.97            −2.378         243.35   **6e**                   9.70           −0.987   27.15
  **4n**   212.50            −2.327         224.16   **6f**                   73.14          −1.864   101.94
  **4o**   219.44            −2.341         230.85   **6g**                   159.33         −2.202   179.62
  **4p**   206.51            −2.315         236.62   **6h**                   125.71         −2.099   147.84
  **4q**   8.93              −0.951         21.50    **6i**                   136.55         −2.135   163.84
  **4r**   44.51             −1.648         56.32    **6j**                   162.30         −2.210   196.45
  **5a**   16.77             −1.225         30.57    **6k**                   135.95         −2.133   161.43
  **5b**   17.74             −1.249         34.51    **6l**                   154.27         −2.188   179.33
  **5c**   15.94             −1.202         34.60    **6m**                   173.23         −2.239   202.97
  **5d**   13.41             −1.127         22.93    **6n**                   24.25          −1.385   40.26
  **5e**   15.35             −1.186         36.10    **6o**                   242.03         −2.384   280.01
  **5f**   79.07             −1.898         95.02    **6p**                   266.25         −2.425   298.26
  **5g**   170.80            −2.232         193.75   **4**                    160.63         −2.206   207.99
  **5h**   215.94            −2.334         229.37   **5**                    238.61         −2.378   279.96
  **5i**   181.69            −2.259         193.87   **6**                    117.12         −2.069   139.85
  **5j**   207.63            −2.317         259.27   **Chlorothalonil ^b^**   4.21           −0.624   8.31

Note: ^a^ All 50% inhibition concentration (IC~50~) values are presented as the means ± SD (*n* = 3), μM; ^b^ Commercial fungicide, chlorothalonil was used as the positive control.

### 2.2.2. Fungicidal Activity of the Title Compounds against *B. cinerea* {#sec2dot2dot2-molecules-21-00130}

The results of the fungicidal activity against *B. cinerea* are summarized in [Table 1](#molecules-21-00130-t001){ref-type="table"}, from which we can see that compounds **4a**--**f**, **4q**, **5a**--**e**,**n** and **6a**--**e** exhibited moderate fungicidal activity against *B. cinerea*. All of the test compounds were less effective than against *C. lagenarium*.

2.3. QSAR Study on the Fungicidal Activity against C. lagenarium {#sec2dot3-molecules-21-00130}
----------------------------------------------------------------

In general, descriptors used in QSAR can be categorized as constitutional, topological, geometrical, electrostatic, quantum chemical, and thermodynamic. There are many regression approaches available for the CODESSA 2.7.15 software, such as the best multi-linear, multi-linear regression, principal component analysis, partial least square regression, and heuristic regression \[[@B26-molecules-21-00130]\]. In view of the number of samples and descriptors used in this study, the heuristic regression was selected for developing the QSAR model.

Determining the number of descriptors is an important step. The "breaking point" rule was used in the improvement of the statistical quality of the model, as described in [Figure 2](#molecules-21-00130-f002){ref-type="fig"}, the *R*^2^ value of the heuristic regression had a dramatic increase before the number of the descriptors reached 5, descriptors with high *t* values were accepted and those with low *t* values were rejected. After the number of the descriptors reached a certain value, the improvement of the regression model became less insignificant (Δ*R*^2^ \< 0.02--0.04) \[[@B27-molecules-21-00130]\]. In addition, the number of the descriptors complies to the linear regressions given by Equation (1): where *N* is the number of sample compounds and *K* is the number of descriptors. Thus, the final model with five descriptors was selected as the best model. The values of the five descriptors of compounds can be found in [Table 2](#molecules-21-00130-t002){ref-type="table"}.

![The "breaking point" rule results.](molecules-21-00130-g002){#molecules-21-00130-f002}

molecules-21-00130-t002_Table 2

###### 

Fungicidal activity and structural descriptors of the title compounds.

  No.   Compd.   pIC~50~   Structural Descriptors                              
  ----- -------- --------- ------------------------ -------- -------- -------- --------
  1     **4a**   −1.1450   1.6111                   0.3570   1.9821   0.1606   0.1084
  2     **4b**   −0.9540   1.6111                   0.3568   1.9820   0.1716   0.1084
  3     **4c**   −1.1050   1.6111                   0.3571   1.9820   0.1628   0.1084
  4     **4d**   −1.1940   1.6111                   0.3532   1.9751   0.1613   0.1078
  5     **4e**   −0.9430   1.6111                   0.3571   1.9851   0.1712   0.1084
  6     **4f**   −1.1580   1.6111                   0.3555   1.9669   0.1631   0.1085
  7     **4g**   −1.7230   1.5946                   0.3558   1.9135   0.1708   0.1088
  8     **4h**   −1.8170   1.5946                   0.3533   1.9134   0.1655   0.1088
  9     **4i**   −1.9790   1.5278                   0.3575   1.9133   0.1603   0.1082
  10    **4j**   −2.2840   1.4872                   0.3595   1.9132   0.1601   0.0821
  11    **4k**   −2.2500   1.4872                   0.3577   1.9133   0.1602   0.0872
  12    **4l**   −2.2760   1.4872                   0.3588   1.9133   0.1601   0.0885
  13    **4m**   −2.3780   1.5250                   0.3658   1.9138   0.1598   0.0751
  14    **4n**   −2.3270   1.5250                   0.3558   1.9133   0.1721   0.0735
  15    **4o**   −2.3410   1.5250                   0.3616   1.9135   0.1608   0.0771
  16    **4p**   −2.3150   1.4688                   0.3342   1.9125   0.1610   0.0843
  17    **4q**   −0.9210   1.5333                   0.3441   1.9135   0.2228   0.0668
  18    **4r**   −1.6480   1.5000                   0.3435   1.9135   0.1607   0.1074
  19    **5a**   −1.2250   1.6111                   0.3597   1.9820   0.1635   0.1077
  20    **5b**   −1.2490   1.6111                   0.3598   1.9820   0.1647   0.1078
  21    **5c**   −1.2020   1.6111                   0.3514   1.9838   0.1594   0.1080
  22    **5d**   −1.1270   1.6111                   0.3596   1.9667   0.1736   0.1079
  23    **5e**   −1.1860   1.6111                   0.3581   1.9788   0.1649   0.1081
  24    **5f**   −1.8980   1.5946                   0.3563   1.9132   0.1670   0.1092
  25    **5g**   −2.2320   1.5278                   0.3602   1.9131   0.1590   0.1068
  26    **5h**   −2.3340   1.4872                   0.3643   1.9126   0.1546   0.0871
  27    **5i**   −2.2590   1.4872                   0.3603   1.9131   0.1587   0.0848
  28    **5j**   −2.3170   1.4872                   0.3614   1.9131   0.1585   0.0859
  29    **5k**   −2.4650   1.5250                   0.3741   1.9121   0.1568   0.0710
  30    **5l**   −2.4530   1.5250                   0.3593   1.9131   0.1752   0.0718
  31    **5m**   −2.2400   1.4286                   0.3432   1.9123   0.1578   0.0713
  32    **5n**   −1.0120   1.5333                   0.3472   1.9131   0.2218   0.0659
  33    **5o**   −2.6170   1.3333                   0.3407   1.9117   0.1409   0.0717
  34    **5p**   −2.6980   1.3636                   0.3408   1.9117   0.1409   0.0687
  35    **5q**   −2.6320   1.3636                   0.3346   1.9118   0.1471   0.0822
  36    **5r**   −2.7160   1.4000                   0.3412   1.9117   0.1406   0.0712
  37    **6a**   −0.8850   1.6111                   0.3569   1.9820   0.1729   0.1084
  38    **6b**   −0.9660   1.6111                   0.3574   1.9820   0.1703   0.1085
  39    **6c**   −1.0120   1.6111                   0.3547   1.9817   0.1736   0.1085
  40    **6d**   −0.9120   1.6111                   0.3571   1.9667   0.1726   0.1085
  41    **6e**   −0.9870   1.6111                   0.3558   1.9669   0.1705   0.1085
  42    **6f**   −1.8640   1.5278                   0.3577   1.9133   0.1700   0.1082
  43    **6g**   −2.2020   1.4872                   0.3573   1.9138   0.1690   0.0823
  44    **6h**   −2.0990   1.4872                   0.3579   1.9133   0.1698   0.0868
  45    **6i**   −2.1350   1.4872                   0.3590   1.9133   0.1699   0.0884
  46    **6j**   −2.2100   1.5250                   0.3665   1.9126   0.1701   0.0746
  47    **6k**   −2.1330   1.5250                   0.3569   1.9133   0.1742   0.0727
  48    **6l**   −2.1880   1.5250                   0.3632   1.9134   0.1692   0.0769
  49    **6m**   −2.2390   1.4688                   0.3344   1.9126   0.1702   0.0841
  50    **6n**   −1.3850   1.5000                   0.3468   1.9133   0.1689   0.1081
  51    **6o**   −2.3840   1.3333                   0.3340   1.9117   0.1719   0.0700
  52    **6p**   −2.4250   1.3636                   0.3340   1.9117   0.1720   0.0694

The best statistical model for the pIC~50~ data had the following statistical characteristics: *R*^2^ = 0.9824, *F* = 203.01, *S*^2^ = 0.0083. This model included five descriptors in descending order according to their statistical significance (*t* values), which is shown in [Table 3](#molecules-21-00130-t003){ref-type="table"}, and the regression coefficients *X* and their standard errors Δ*X* are also listed. The comparison between the experimental and predicted pIC~50~ is listed in [Table 4](#molecules-21-00130-t004){ref-type="table"}, and the plot of the comparison between the predicted and experimental values is shown in [Figure 3](#molecules-21-00130-f003){ref-type="fig"}. The five descriptor QSAR model equation is described in the following Equation (2) ([Figure 4](#molecules-21-00130-f004){ref-type="fig"}): *N* = 52, *R*^2^ = 0.9824, *F* = 203.01, *S*^2^ = 0.0083.

![Experimental pIC~50~ *vs.* predicted pIC~50~.](molecules-21-00130-g003){#molecules-21-00130-f003}

![Optimized structures and HOMO energy maps for compounds **5c**,**f** from the DFT calculations of Gaussian 03W. The green parts represent positive molecular orbitals, and the red parts represent negative molecular orbitals.](molecules-21-00130-g004){#molecules-21-00130-f004}

molecules-21-00130-t003_Table 3

###### 

The best five-descriptor model.

  Descriptor No.   *X*                ±Δ*X*             *t*-Text   Descriptor
  ---------------- ------------------ ----------------- ---------- -----------------
  0                −2.4230 × 10       4.1535            −3.0433    Intercept
  1                −6.2613 × 10^−1^   5.2603 × 10^−1^   −1.1903    *N*~o~ ^a^
  2                −1.0225 × 10       2.9561            −3.4591    *q*^C^~max~ ^b^
  3                1.2075 × 10        8.0165 × 10^−1^   15.0631    MAOEP ^c^
  4                1.2464 × 10        2.0587            6.0544     *q*^H^~max~ ^d^
  5                1.6086 × 10        1.8059            8.9076     *q*^H^~min~ ^e^

Note: ^a^ Number of occupied electronic levels of atoms; ^b^ Max. net atomic charge for a C atom; ^c^ Max. atomic orbital electronic population; ^d^ Max. net atomic charge for a H atom; ^e^ Min. net atomic charge for a C atom.

molecules-21-00130-t004_Table 4

###### 

The difference between the experimental pIC~50~ and predicted pIC~50~.

  No.   Compd.   Calc. pIC~50~   Exp. pIC~50~   Difference   No.   Compd.   Calc. pIC~50~   Exp. pIC~50~   Difference
  ----- -------- --------------- -------------- ------------ ----- -------- --------------- -------------- ------------
  1     **4a**   −1.1403         −1.1450        0.0047       27    **5i**   −2.3856         −2.2590        −0.1266
  2     **4b**   −1.0128         −0.9540        −0.0588      28    **5j**   −2.3869         −2.3170        −0.0699
  3     **4c**   −1.0988         −1.1050        0.0062       29    **5k**   −2.5972         −2.4650        −0.1322
  4     **4d**   −1.2533         −1.1940        −0.0593      30    **5l**   −2.3140         −2.4530        0.1390
  5     **4e**   −0.8153         −0.9430        0.1277       31    **5m**   −2.2529         −2.2400        −0.0129
  6     **4f**   −1.1974         −1.1580        −0.0394      32    **5n**   −0.9584         −1.0120        0.0536
  7     **4g**   −1.7783         −1.7230        −0.0553      33    **5o**   −2.6263         −2.6170        −0.0093
  8     **4h**   −1.7431         −1.8170        0.0739       34    **5p**   −2.8078         −2.6980        −0.1098
  9     **4i**   −2.0285         −1.9790        −0.0495      35    **5q**   −2.4778         −2.6320        0.1542
  10    **4j**   −2.3147         −2.2840        −0.0307      36    **5r**   −2.8579         −2.7160        −0.1419
  11    **4k**   −2.2508         −2.2500        −0.0008      37    **6a**   −0.9917         −0.8850        −0.1067
  12    **4l**   −2.2089         −2.2760        0.0671       38    **6b**   −1.0220         −0.9660        −0.0560
  13    **4m**   −2.3273         −2.3780        0.0507       39    **6c**   −0.9105         −1.0120        0.1015
  14    **4n**   −2.2477         −2.3270        0.0793       40    **6d**   −1.0028         −0.9120        −0.0908
  15    **4o**   −2.2751         −2.3410        0.0659       41    **6e**   −1.0382         −0.9870        −0.0512
  16    **4p**   −2.3821         −2.3150        −0.0671      42    **6f**   −1.8806         −1.8640        −0.0166
  17    **4q**   −1.0839         −0.9510        −0.1329      43    **6g**   −2.1368         −2.2020        0.0652
  18    **4r**   −1.6793         −1.6480        −0.0313      44    **6h**   −2.0781         −2.0990        0.0209
  19    **5a**   −1.1940         −1.2250        0.0310       45    **6i**   −2.0438         −2.1350        0.0912
  20    **5b**   −1.2255         −1.2490        0.0235       46    **6j**   −2.2545         −2.2100        −0.0445
  21    **5c**   −1.1129         −1.2020        0.0891       47    **6k**   −2.1958         −2.1330        −0.0628
  22    **5d**   −1.1579         −1.1270        −0.0309      48    **6l**   −2.0901         −2.1880        0.0979
  23    **5e**   −1.1386         −1.1860        0.0474       49    **6m**   −2.1068         −2.2390        0.1322
  24    **5f**   −1.8257         −1.8980        0.0723       50    **6n**   −1.5095         −1.3850        −0.1245
  25    **5g**   −2.2060         −2.2320        0.0260       51    **6o**   −2.3109         −2.3840        0.0731
  26    **5h**   −2.2643         −2.3340        0.0697       52    **6p**   −2.4467         −2.4250        −0.0217

The internal validation and the "leave-one-out" cross-validation methods were used to validate the developed QSAR model \[[@B28-molecules-21-00130]\]. The internal validation was carried out by dividing the compound data into three subsets A--C, with **17**, **17** and **18** compounds respectively. The compounds **1**, **4**, **7**, **10**, *etc.*, went into the first subset (A); **2**, **5**, **8**, **11**, *etc.*, went into the second subset (B); and **3**, **6**, **9**, **12**, *etc.*, went into the third subset (C). Two of the three subsets, (A and B), (A and C), and (B and C), consist the training set while the remaining subset was treated as a test set. The correlation equations were derived from each of the training sets using the same descriptors and then used to predict values for the corresponding test set \[[@B29-molecules-21-00130]\]. Internal validation results are presented in [Table 5](#molecules-21-00130-t005){ref-type="table"}. The *R*~Training~^2^ and *R*~Test~^2^ are within 5% for all three sets, and the average values of *R*~Training~^2^ = 0.9833 and *R*~Test~^2^ = 0.9855 were close to the overall *R*^2^ value. Thus, the obtained QSAR model obtained demonstrated the predictive power of 3-fold cross-validation. Meanwhile, the "leave-one-out" method was completed in a similar manner to the internal validation. Every fourth compound (**1**, **5**, **9**, **13**, *etc.*) was put into an external test set, and the remaining compounds were left in the training set. The QSAR model containing the same five descriptors was obtained with *R*^2^ = 0.9862 from the training set. When the same QSAR model was applied on the test set, *R*^2^ = 0.9789 was observed. Therefore, the "leave-one out" cross-validation results were also satisfactory.
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###### 

Internal validation of the QSAR model ^a^.

  Training Set   *N*   *R*^2^   *F*      *S*^2^   Test Set   *N*   *R*^2^   *F*      *S*^2^
  -------------- ----- -------- -------- -------- ---------- ----- -------- -------- --------
  A + B          34    0.9862   211.53   0.0095   C          18    0.9896   214.65   0.0086
  B + C          35    0.9797   201.69   0.0112   A          17    0.9807   204.11   0.0104
  A + C          35    0.9841   207.43   0.0090   B          17    0.9862   209.81   0.0092
  Average              0.9833   206.83   0.0099   Average          0.9855   209.52   0.0094

Note: ^a^ Compounds A: **1**, **4**, **7**, **10**, **13**, **16**, **19**, **22**, **25**, **28**, **31**, **34**, **37**, **40**, **43**, **46**, **49**; Compounds B: **2**, **5**, **8**, **11**, **14**, **17**, **20**, **23**, **26**, **29**, **32**, **35**, **38**, **41**, **44**, **47**, **50**; Compounds C: **3**, **6**, **9**, **12**, **15**, **18**, **21**, **24**, **27**, **30**, **33**, **36**, **39**, **42**, **45**, **48**, **51**, **52**.

Descriptors involved in this model revealed the relationship between the compounds and the fungicidal activity. The 1st and 3rd most important descriptors obtained in the model were the number of occupied electronic levels of atoms and maximum atomic orbital electronic population, which belong to quantum-chemically descriptors and have a significant effect on the fungicidal activity. The number of occupied electronic levels of atoms depends directly on the quantum-chemically calculated charge distribution in the molecules, and therefore describes the polar interactions between molecules \[[@B30-molecules-21-00130],[@B31-molecules-21-00130]\]. This study found that the derivatives with electron-withdrawing groups on the benzene ring showed higher *N*~o~ values than those with electron-donating groups. Maximum atomic orbital electronic population for a given atomic species in the molecule is an important index to describe the nucleophilicity of the molecule, which is directly related to molecular nucleophilic capacity and characterizes the susceptibility of the molecule to electrophilic attack \[[@B32-molecules-21-00130]\]. In Equation (2), the maximum atomic orbital electronic population and pIC~50~ are positively correlated, which suggested that the electron withdrawing substitution groups of the derivatives are beneficial for the fungicidal activity against *C. lagenarium*. In fact, the α,β-unsaturated carbonyl system (Michael acceptor), which had higher electron deficiency induced by electron-withdrawing groups, can be easily attacked by bionucleophiles \[[@B33-molecules-21-00130],[@B34-molecules-21-00130]\]. Therefore, the obtained QSAR study result partially met the above SAR study conclusion.

The 2nd, 4th and 5th descriptors obtained in the model were the maximum net atomic charge for a C atom, maximum net atomic charge for an H atom, and minimum net atomic charge for an H atom. These three descriptors belong to electrostatic descriptors, and they reflect characteristics of the charge distribution of the molecules \[[@B35-molecules-21-00130],[@B36-molecules-21-00130]\]. Thus, the electrostatic descriptors play an important role in influencing the fungicidal activity of compounds. In Equation (2), appearance with a positive sign in the model indicated that a molecule with a higher descriptor value had a higher pIC~50~. On the contrary, a negative sign in the model indicated that a molecule with a lower descriptor value had a higher pIC~50~.

2.4. Cytotoxic Activity of the Representative Compounds against Human Tumor Cells Line (HepG2) {#sec2dot4-molecules-21-00130}
----------------------------------------------------------------------------------------------

As a fact, compounds containing the α-methylene-γ-butyrolactone structure often exhibit a high toxicity potential against mammalian cells \[[@B37-molecules-21-00130],[@B38-molecules-21-00130]\]. In order to ensure the selectivity of the fungicidal effects, the cytotoxicity of 24 representative derivatives was tested in a human tumor cells line (HepG2). The result is listed in [Table 6](#molecules-21-00130-t006){ref-type="table"}, which indicated that the QSAR underlying the fungicidal and cytotoxic effects of these representative compounds are different. For instance, compound **6a** has the highest fungicidal activity with IC~50~ = 7.68 μM (against *C. lagenarium*) but moderate cytotoxic activity with IC~50~ = 30.2 μM (against HepG2 cell line), while, compound **4i** has low fungicidal activity with IC~50~ = 95.38 μM (against *C. lagenarium*) but high cytotoxic activity with IC~50~ = 5.3 μM (against HepG2 cell line). Through QSAR studies on fungicidal and antitumor activity of α-methylene-γ-butyrolactone derivatives, these are important points that need further investigation to seek high activity derivatives with weak cytotoxicity.
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###### 

*In vitro* fungicidal activity of compounds against *C. lagenarium* and cytotoxic activity against a human tumor cells line (HepG2).

  No.   Compd.   IC~50~ (μM) (against *C. lagenarium*)   IC~50~ (μM) (against HepG2 Cell Line)
  ----- -------- --------------------------------------- ---------------------------------------
  1     **4b**   8.99                                    22.4
  2     **4e**   8.76                                    21.7
  3     **4g**   52.87                                   18.3
  4     **4i**   95.38                                   5.3
  5     **4k**   177.96                                  28.5
  6     **4o**   219.44                                  25.0
  7     **4p**   206.51                                  19.5
  8     **4q**   8.93                                    27.3
  9     **5a**   16.77                                   28.4
  10    **5d**   13.41                                   35.6
  11    **5i**   181.69                                  85.2
  12    **5l**   283.99                                  29.0
  13    **5m**   173.74                                  23.8
  14    **5p**   499.33                                  \>131.7
  15    **5r**   519.42                                  38.4
  16    **6a**   7.68                                    30.2
  17    **6d**   8.17                                    20.9
  18    **6f**   73.14                                   18.5
  19    **6g**   159.33                                  22.0
  20    **6l**   154.27                                  58.6
  21    **6n**   24.25                                   15.7
  22    **6o**   242.03                                  \>108.2
  23    **4**    160.63                                  23.3
  24    **6**    117.12                                  17.9

3. Materials and Methods {#sec3-molecules-21-00130}
========================

3.1. General Information {#sec3dot1-molecules-21-00130}
------------------------

Chlorothalonil was purchased from Xiangtan Huayuan Fine-Chem Co. Ltd. (Xiangtan, China). 4-Dimethylaminopyridine (DMAP), *N*,*N*-dicyclohexylcarbodiimide (DCC) and carboxylic acids were purchased from J & K Chemical Ltd. (Beijing, China). Other reagents and solvents were obtained locally. All solvents were dried, and redistilled before use. The water used was redistilled and ion-free. Analytical thin-layer chromatography (TLC) was performed on silica gel GF~254~. Column chromatographic (CC) purification was carried out using silica gel (200--300 mesh). Above silica gel was obtained from Qingdao Haiyang Chemical Co., Ltd. (Qingdao, China). The melting points of the synthetic derivatives were determined on an *X*-6 apparatus (Beijing Tech., Beijing, China) and are uncorrected. Nuclear magnetic resonance (NMR) experiments were performed on an Avance 400/500 MHz instrument (Bruker, Bremerhaven, Germany). HR-MS (ESI) were obtained using a Bruker Apex-Ultra 7.0 T spectrometer. Reaction progress was monitored by thin-layer chromatography on silica gel GF-254 with detection by UV light.

3.2. Synthetic Procedures {#sec3dot2-molecules-21-00130}
-------------------------

### 3.2.1. General Synthetic Procedure for the Intermediate Compounds {#sec3dot2dot1-molecules-21-00130}

α-(Bromomethyl)acrylic acid was synthesized according to our previous report \[[@B21-molecules-21-00130]\]. Hydroxybenzaldehyde (122.1 mg, 1.0 mmol), α-(bromomethyl) acrylic acid (198.0 mg, 1.2 mmol), and indium powder (136.0 mg, 1.2 mmol) were added to THF (10.0 mL) at room temperature. 6.0 M HCl was added to the above mixture when the starting aldehyde disappeared according to TLC analysis and stirring was continued for 6 hours. Then, the mixture was extracted with ethyl acetate (3 × 10 mL) and the organic phase dried over anhydrous Na~2~SO~4~ and evaporated under reduced pressure. The resulting residue was purified using preparative chromatography on silica gel eluting with 0%--40% ethyl acetate in petroleum ether. These intermediate compounds were used to prepare the target compounds.

*4-(4-Hydroxyphenyl)-2-methylenebutyrolactone* (**4**). White crystals; mp: 79--81 °C; 87% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 2.88 (ddt, 1H, *J* = 17.2, 6.5, 2.6 Hz, C*H*HC=CH~2~), 3.30 (ddt, 1H, *J =* 17.2, 8.0, 2.0 Hz, CH*H*C=CH~2~), 5.43 (t, 1H, *J =* 7.1 Hz, OCH), 5.70 (t, 1H, *J =* 2.1 Hz, C=C*H*H), 6.28 (t, 1H, *J =* 2.6 Hz, C=CH*H*), 6.84--7.11 (m, 4H, Ar*H*); ^13^C-NMR (100 MHz, CDCl~3~): δ 35.85, 79.14, 115.86, 123.05, 127.44, 130.59, 134.54, 156.76, 171.59; HR-MS (ESI): *m*/*z* calcd for C~11~H~11~O~3~ (\[M + H\]^+^) 191.0703, found 191.0703.

*4-(2-Hydroxyphenyl)-2-methylenebutyrolactone* (**5**)*.* Colourless oil; 81% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 2.95 (ddt, 1H, *J* = 17.4, 5.9, 2.7 Hz, C*H*HC=CH~2~), 3.42 (ddt, 1H, *J =* 17.4, 8.4, 2.4 Hz, CH*H*C=CH~2~), 5.66 (t, 1H, *J =* 2.4 Hz, C=C*H*H), 5.79 (dd, 1H, *J =* 8.3 6.1 Hz, OCH), 6.29 (t, 1H, *J =* 2.8 Hz, C=CH*H*), 6.86--7.23 (m, 4H, Ar*H*); ^13^C-NMR (100 MHz, CDCl~3~): δ 34.67, 76.23, 115.93, 120.13, 122.77, 126.04, 126.28, 129.65, 134.82, 153.67, 172.26; HR-MS (ESI): *m*/*z* calcd for C~11~H~11~O~3~ (\[M + H\]^+^) 191.0703, found 191.0703.

*4-(3-Hydroxyphenyl)-2-methylenebutyrolactone* (**6**)*.* White crystal ; mp: 78--79 °C; 81% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 2.82 (ddt, 1H, *J =* 17.2, 6.3, 2.8 Hz, C*H*HC=CH~2~), 3.30 (ddt, 1H, *J =* 17.2, 8.1, 2.3 Hz, CH*H*C=CH~2~), 5.41 (t, 1H, *J =* 7.4 Hz, OCH), 5.66 (t, 1H, *J =* 2.3 Hz, C=C*H*H), 6.25 (t, 1H, *J =* 2.7 Hz, C=CH*H*), 6.76--7.19 (m, 4H, Ar*H*); ^13^C-NMR (100 MHz, CDCl~3~): δ 35.91, 78.62, 112.44, 115.87, 117.09, 123.31, 130.16, 134.04, 141.10, 156.71, 171.55; HR-MS (ESI): *m*/*z* calcd for C~11~H~11~O~3~ (\[M + H\]^+^) 191.0703, found 191.0703.

### 3.2.2. General Synthetic Procedure for Ester Compounds {#sec3dot2dot2-molecules-21-00130}

4-Dimethylaminopyridine (DMAP, 30.0 mg, 0.2 mmol) and the appropriate intermediate compounds 4, 5 or 6 (196.0 mg, 1.1 mmol) were added to anhydrous CH~2~Cl~2~ (15.0 mL) containing the respective carboxylic acid (1.1 mmol). Then the mixture was cooled to 0 °C. *N*,*N*-dicyclohexyl-carbodiimide (DCC, 226.0 mg, 1.1 mmol) dissolved in anhydrous CH~2~Cl~2~ (10.0 mL) was added dropwise into the mixture over a period of 10 min at 0 °C and the mixture was then stirred at room temperature until the reaction was complete according to the TLC analysis. Then, the mixture was filtered. Finally, the residual organic layers were extracted by ethyl acetate (3 × 30 mL) and dried over anhydrous Na~2~SO~4~. After filtering, the solution was evaporated under vacuum. The target compounds were purified by column chromatography on silica gel eluting with 0%--40% ethyl acetate in petroleum ether. The structures of all ester derivatives were characterized by ^1^H-NMR, ^13^C-NMR, and HR-ESI-MS, and the data are listed below.

*4-\[4-(2-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4a**) White solid; mp: 187.2--187.9 °C; 40% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.05 (dd, *J* =7.8, 1.1 Hz, 1H, Ar*H*), 7.56--7.47 (m, 3H, Ar*H*), 7.44--7.37 (m, 4H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.61--5.52 (m, 1H, OC*H*), 5.56 (d, *J* = 7.7 Hz, 1H, C=CH*H*), 3.50--3.37 (m, 1H, C*H*HC=CH~2~), 3.04--2.82 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.06, 163.97, 150.70, 137.72, 134.50, 133.94, 133.41, 131.97, 131.44, 128.99, 126.77, 122.83, 122.16, 77.62, 77.05, 76.73, 36.36, 1.05; HR-MS (ESI): *m*/*z* calcd for C~18~H~13~ClNaO~4~ (\[M + Na\]^+^) 351.0394, found 351.0395.

*4-\[4-(3-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4b**) White solid; mp: 168.8--169.2 °C; 54% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.24 (m, 1H, Ar*H*), 7.69--7.56 (m, 1H, Ar*H*), 7.54--7.34 (m, 3H, Ar*H*), 7.31--7.19 (m, 3H, Ar*H*), 6.37 (dd, *J* = 14.9, 12.1 Hz, 1H, C=C*H*H), 5.76 (dd, *J* = 14.6, 12.2 Hz, 1H, OC*H*), 5.60 (dd, *J* = 20.0, 12.6 Hz, 1H, C=CH*H*), 3.54--3.37 (m, 1H, C*H*HC=CH~2~), 3.02--2.88 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 150.76, 137.71, 134.84, 133.86, 131.05, 130.22, 129.95, 128.31, 126.75, 122.74, 122.02, 77.31, 77.01, 76.75, 36.30, 29.70; HR-MS (ESI): *m*/*z* calcd for C~18~H~13~ClNaO~4~ (\[M + Na\]^+^) 351.0394, found 351.0395.

*4-\[4-(4-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4c**) White solid; mp: 171.3--171.6 °C; 65% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.30--8.02 (m, 2H, Ar*H*), 7.68--7.14 (m, 6H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.72 (t, *J* = 2.5 Hz, 1H, OC*H*), 5.60--5.47 (m, 1H, C=CH*H*), 3.43 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.94 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.01, 150.82, 140.37, 137.63, 133.95, 131.59, 129.04, 126.73, 122.80, 122.16, 77.39, 77.04, 76.72, 36.31. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~ClNaO~4~ (\[M + Na\]^+^) 351.0394, found 351.0395.

*4-\[4-(2-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4d**) White crystal; mp: 174.5--174.9 °C; 62% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.04 (dd, *J* = 7.5, 1.7 Hz, 1H, Ar*H*), 7.91--7.68 (m, 1H, Ar*H*), 7.56--7.08 (m, 6H, Ar*H*), 6.36 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.74 (t, *J* = 2.4 Hz, 1H, OC*H*), 5.61--5.50 (m, 1H, C=CH*H*), 3.56--3.08 (m, 1H, C*H*HC=CH~2~), 3.05--2.67 (m, 1H, CH*H*C=CH~2~). ^13^C-NMR (125 MHz, CDCl~3~): δ 134.69, 133.30, 131.85, 127.36, 126.70, 122.73, 122.03, 77.32, 77.01, 76.75, 36.35, 29.70, 14.99.HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9890, found 394.9889.

*4-\[4-(3-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4e**) White crystal; mp: 176.5--176.8 °C; 45% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.37 (s, 1H, Ar*H*), 8.16 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.80 (d, *J* = 7.9 Hz, 1H, Ar*H*), 7.56--7.19 (m, 4H, Ar*H*), 6.36 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.75 (t, *J* = 2.4 Hz, 1H, OC*H*), 5.66--5.52 (m, 1H, C=CH*H*), 5.42 (dd, *J* = 10.6, 5.3 Hz, 1H, Ar*H*), 3.57--3.37 (m, 1H, C*H*HC=CH~2~), 2.95 (s, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 136.73, 133.16, 132.05, 131.69, 130.22, 128.79, 126.91, 126.53, 122.77, 122.20, 78.63, 77.34, 77.03, 76.78, 40.03, 36.36, 29.72, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9890, found 394.9889.

*4-\[4-(4-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4f**) White crystal; mp: 175.1--175.6 °C; 52% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.10 (d, *J* = 8.5 Hz, 2H, Ar*H*), 7.72 (t, *J* = 12.5 Hz, 4H, Ar*H*), 6.38 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.76 (t, *J* = 2.4 Hz, 1H, OC*H*), 5.65--5.54 (m, 1H, C=CH*H*), 5.43 (dd, *J* = 10.7, 5.2 Hz, 2H, Ar*H*), 3.55--3.36 (m, 1H, C*H*HC=CH~2~), 3.04--2.93 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 150.78, 136.95, 132.05, 131.69, 129.05, 128.28, 126.76, 122.75, 122.08, 78.62, 77.28, 77.03, 76.78, 40.03, 36.36, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9890, found 394.9889.

*4-\[4-(3-Benzonitrile)phenyl\]-2-methylenebutyrolactone* (**4g**) Yellow oil; 54% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.52 (s, 1H, Ar*H*), 8.45 (d, *J* = 8.0 Hz, 1H, Ar*H*), 7.95 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.70 (t, *J* = 7.9 Hz, 1H, Ar*H*), 7.29 (t, *J* = 4.3 Hz, 4H, Ar*H*), 6.36 (t, *J* = 2.8 Hz, 1H, 1H, C=C*H*H), 5.75 (t, *J* = 2.4 Hz, 1H, OC*H*), 5.65--5.56 (m, 1H, C=CH*H*), 3.46 (ddd, *J* = 10.5, 5.7, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.96 (ddt, *J* = 17.0, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~), ^13^C-NMR (125 MHz, CDCl~3~): δ 163.13, 150.51, 138.01, 136.69, 134.16, 133.82, 130.69, 129.73, 126.83, 122.82, 121.90, 113.36, 77.26, 77.01, 76.76, 49.17, 36.29, 33.95, 25.62. HR-MS (ESI): *m*/*z* calcd for C~19~H~13~NNaO~4~ (\[M + Na\]^+^) 342.0736, found 342.0740.

*4-\[4-(4-Benzonitrile)phenyl\]-2-methylenebutyrolactone* (**4h**) Yellow oil; 57% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.51--8.39 (m, 1H, Ar*H*), 8.34 (t, *J* = 7.3 Hz, 2H, Ar*H*), 7.98 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.85 (s, 2H, Ar*H*), 7.73 (t, *J* = 7.9 Hz, 1H, Ar*H*), 6.37 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 6.25 (t, *J* = 2.9 Hz, 1H, Ar*H*), 5.75 (t, *J* = 2.4 Hz, 1H, OC*H*), 5.71--5.64 (m, 2H, Ar*H*), 5.61--5.55 (m, 1H, C=CH*H*), 3.49--3.41 (m, 1H, C*H*HC=CH~2~), 3.38--3.28 (m, 1H, CH*H*C=CH~2~). ^13^C-NMR (125 MHz, CDCl~3~): δ 137.00, 133.71, 132.43, 130.67, 129.88, 127.05, 126.80, 123.06, 122.84, 121.89, 77.26, 77.01, 76.75, 73.73, 49.17, 36.28, 33.95, 29.69, 25.64. HR-MS (ESI): *m*/*z* calcd for C~19~H~13~NNaO~4~ (\[M + Na\]^+^) 342.0736, found 342.0740.

*4-(4-Benzoyloxyphenyl)-2-methylenebutyrolactone* 4-(4-Benzoyloxyphenyl)-2-methylenebutyrolactone (**4i**) White solid; mp: 223.3--223.7 °C; 55% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.25 (d, *J* = 8.3 Hz, 5H, Ar*H*), 7.70 (t, *J* = 7.4 Hz, 4H, Ar*H*), 6.38 (s, 1H, C=C*H*H), 5.76 (d, *J* = 2.4 Hz, 1H, OC*H*), 5.63--5.55 (m, 1H, C=CH*H*), 4.11 (dd, *J* = 15.3, 7.9 Hz, 1H, C*H*HC=CH~2~), 3.47 (dd, *J* = 17.1, 8.1 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 133.76, 130.21, 128.64, 126.72, 122.12, 78.70, 77.28, 77.03, 76.77, 40.04, 36.41, 29.72, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~14~NaO~4~ (\[M + Na\]^+^) 317.0784, found 317.0788.

*4-\[4-(2-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4j**) White crystals; mp: 189.6--190.1 °C; 53% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.18 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.58--7.46 (m, 1H, Ar*H*), 7.40 (t, *J* = 14.7 Hz, 2H, Ar*H*), 7.35 (t, *J* = 7.7 Hz, 2H, Ar*H*), 7.28 (t, *J* = 6.3 Hz, 2H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.64--5.40 (m, 1H, OC*H*), 3.45 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 3.05--2.85 (m, 1H, CH*H*C=CH~2~), 2.70 (s, 3H, ArC*H*~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.00, 165.67, 151.00, 141.44, 137.39, 134.02, 132.91, 126.65, 125.97, 125.11, 122.96, 122.66, 122.35, 77.47, 77.30, 77.05, 76.79, 36.27, 21.95; HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0937.

*4-\[4-(3-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4k**) White crystals; mp: 186.2--186.6 °C; 52% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.00 (d, *J* = 8.9 Hz, 2H, Ar*H*), 7.57--7.14 (m, 6H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.72 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.58--5.50 (m, 1H, OC*H*), 3.43 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 3.05--2.82 (m, 1H, CH*H*C=CH~2~), 2.45 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.03, 165.28, 151.07, 138.51, 137.37, 134.55, 134.01, 130.71, 129.19, 128.53, 127.37, 126.67, 122.26, 77.48, 77.28, 77.02, 76.77, 36.32, 21.30. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0937.

*4-\[4-(4-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4l**) White crystals; mp: 184.5--185.1 °C; 60% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.11 (d, *J* = 8.2 Hz, 2H, Ar*H*), 7.56--7.19 (m, 6H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.74 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.64--5.40 (m, 1H, OC*H*), 3.45 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 3.08--2.82 (m, 1H, CH*H*C=CH~2~), 2.48 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.99, 165.13, 151.11, 144.63, 138.51, 137.30, 134.03, 130.24, 129.34, 127.37, 126.58, 122.65, 122.27, 77.48, 77.27, 77.02, 76.76, 36.32, 21.77. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0937.

*4-\[4-(2-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4m**) White crystals; mp: 179.8--180.4 °C; 60% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.02 (dd, *J* = 8.0, 1.7 Hz, 1H, Ar*H*), 7.56 (td, *J* = 8.2, 1.8 Hz, 1H, Ar*H*), 7.40--6.97 (m, 6H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.59--5.48 (m, 1H, OC*H*), 3.94 (s, 3H, ArOC*H*~3~), 3.42 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 9.3, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.08, 164.25, 159.97, 151.08, 137.20, 134.54, 134.06, 132.25, 126.56, 122.67, 122.37, 120.25, 112.25, 77.55, 77.30, 77.04, 76.79, 56.07, 36.34; HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0891.

*4-\[4-(3-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4n**) White crystals; mp: 185.7--186.2 °C; 44% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.85 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.74 (s, 4H, Ar*H*), 6.38 (s, 1H, C=C*H*H), 5.76 (s, 1H, C=CH*H*), 5.66--5.56 (m, 1H, OC*H*), 5.44 (dd, *J* = 10.7, 5.2 Hz, 3H, Ar*H*), 4.35 (s, 3H, ArOC*H*~3~), 4.11 (dd, *J* = 17.0, 9.5 Hz, 1H, C*H*HC=CH~2~), 3.47 (dd, *J* = 17.1, 8.1 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.03, 164.28, 159.77, 129.67, 126.76, 122.64, 122.10, 120.32, 114.60, 78.69, 77.28, 77.03, 76.78, 55.56, 40.04, 36.41, 29.72, 15.00. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0891.

*4-\[4-(4-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**4o**) White crystals; mp: 184.5--185.2 °C; 51% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.28--8.00 (m, 2H, Ar*H*), 7.53--7.30 (m, 2H, Ar*H*), 7.28--7.14 (m, 2H, Ar*H*), 7.02--6.95 (m, 2H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.58--5.41 (m, 1H, OC*H*), 3.90 (s, 3H, ArOC*H*~3~), 3.49--3.33 (m, 1H, C*H*HC=CH~2~), 2.94 (ddd, *J* = 14.2, 6.3, 3.1 Hz, 1H, CH*H*C=CH~2~);^13^C-NMR (125 MHz, CDCl~3~): δ 170.08, 164.83, 164.05, 159.97, 151.16, 137.23, 134.05, 132.36, 126.64, 122.70, 122.33, 121.55, 113.92, 77.46, 77.06, 76.74, 55.56, 36.32. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0891.

*4-\[4-(Propionyloxy)phenyl\]-2-methylenebutyrolactone* (**4p**) Colourless oil; 68% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.74 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.63--5.46 (m, 1H, OC*H*), 5.39 (dd, *J* = 10.7, 5.2 Hz, 3H,CH~3~CH~2~), 3.44 (dd, *J* = 17.1, 8.1 Hz, 1H, C*H*HC=CH~2~), 3.03--2.90 (m, 1H, CH*H*C=CH~2~), 1.67 (s, 2H,CH~3~CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 178.99, 172.87, 150.84, 136.53, 126.63, 122.64, 78.68, 77.39, 77.06, 76.81, 39.98, 36.33, 27.75, 14.97. HR-MS (ESI): *m*/*z* calcd for C~14~H~14~NaO~4~ (\[M + Na\]^+^) 269.0784, found 269.0786.

*\[4-(4-Hydroxy-3-methoxycinnamoyloxy)phenyl\]-2-methylenebutyrolactone* (**4q**) Yellow oil; 45% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.80 (d, *J* = 15.9 Hz, 1H, ArOH), 7.36 (d, *J* = 8.6 Hz, 2H, Ar*H*), 7.21 (dd, *J* = 21.2, 12.6 Hz, 2H, Ar*H*), 7.16--7.05 (m, 2H, CH=CH), 6.95 (d, *J* = 8.2 Hz, 1H, Ar*H*), 6.47 (d, *J* = 15.9 Hz, 1H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 6.10 (s, 1H, Ar*H*), 5.71 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.58--5.44 (m, 1H, OC*H*),4.02--3.82 (m, 3H, ArOC*H*~3~), 3.49--3.29 (m, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 12.2, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.02, 165.56, 151.01, 148.60, 147.01, 137.172, 134.06, 126.63, 123.51, 122.18, 114.92, 114.22, 109.66, 76.72, 56.01, 49.16, 36.28, 33.94, 30.90, 29.69, 25.62. HR-MS (ESI): *m*/*z* calcd for C~21~H~18~NaO~6~ (\[M + Na\]^+^) 389.0997, found 389.0995.

*4-\[4-(Cinnamoyloxy)phenyl\]-2-methylenebutyrolactone* (**4r**) Yellow oil; 43% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.88 (d, *J* = 16.0 Hz, 1H, Ar*H*), 7.64--7.53 (m, 2H, Ar*H*), 7.47--7.40 (m, 2H, Ar*H*), 7.39--7.32 (m, 2H, Ar*H*), 7.28--7.16 (m, 2H, CH=CH), 6.63 (d, *J* = 16.0 Hz, 1H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.63--5.46 (m, 1H, OC*H*), 3.41 (ddt, *J* = 17.1, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 9.4, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (100 MHz, CDCl~3~): δ 170.06, 165.31, 150.88, 146.99, 137.31, 134.05, 130.86, 129.05, 128.37, 126.65, 122.72, 122.16, 116.99, 77.44, 77.06, 76.74, 36.30, 33.94, 30.91, 29.63. HR-MS (ESI): *m*/*z* calcd for C~20~H~16~NaO~4~ (\[M + Na\]^+^) 343.0940, found 343.0941.

*4-\[2-(3-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5a**) White solid; mp: 201.3--201.8 °C; 54% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.16 (t, *J* = 1.8 Hz, 1H, Ar*H*), 8.08 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.71--7.59 (m, 1H, Ar*H*), 7.53--7.45 (m, 2H, Ar*H*), 7.43 (dt, *J* = 7.8, 3.9 Hz, 1H, Ar*H*), 7.34 (dd, *J* = 9.4, 4.9 Hz, 1H, Ar*H*), 7.21 (dd, *J* = 8.0, 0.7 Hz, 1H, Ar*H*), 6.24 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.68 (dd, *J* = 8.4, 6.2 Hz, 1H, C=CH*H*), 5.63 (t, *J* = 2.5 Hz, 1H, OC*H*), 3.32 (ddt, *J* = 17.4, 8.4, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.90 (ddt, *J* = 17.4, 5.9, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.96, 163.75, 147.46, 135.04, 134.19, 133.51, 132.32, 130.46, 129.67, 128.34, 126.85, 126.40, 123.09, 122.85, 77.31, 77.06, 76.80, 35.20; HR-MS (ESI): *m*/*z* calcd for C~18~H~14~ClO~4~ (\[M + Na\]^+^) 325.0574, found 325.0575.

*4-\[2-(4-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5b**) White solid; mp: 208.7--209.3 °C; 48% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.17--8.07 (m, 2H, Ar*H*), 7.59--7.45 (m, 4H, Ar*H*), 7.26 (s, 2H, Ar*H*), 6.22 (s, 1H, C=C*H*H), 5.67 (dd, *J* = 8.4, 6.1 Hz, 1H, OC*H*), 5.61 (s, 1H, C=CH*H*), 3.30 (ddt, *J* = 17.4, 8.4, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.90 (ddt, *J* = 17.4, 5.9, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 168.96, 165.75, 146.45, 137.04, 134.29, 131.58, 129.66, 129.25, 128.81, 128.26, 126.76, 126.40, 123.09, 122.97, 77.35, 77.03, 76.72, 30.87. HR-MS (ESI): *m*/*z* calcd for C~18~H~14~ClO~4~ (\[M + Na\]^+^) 325.0572, found 325.0575.

*4-\[2-(2-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5c**) White crystal; mp: 204.6--205.1 °C; 43% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.05 (dd, *J* = 7.5, 1.9 Hz, 1H, Ar*H*), 7.79 (dd, *J* = 7.7, 1.2 Hz, 1H, Ar*H*), 7.56--7.16 (m, 6H, Ar*H*), 6.25 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.76 (dd, *J* = 8.3, 6.2 Hz, 1H, OC*H*), 5.66 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.60--3.22 (m, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 164.19, 147.43, 134.88, 132.39, 131.97, 130.59, 129.59, 127.57, 126.81, 126.29, 122.88, 122.69, 122.42, 77.28, 77.03, 76.78, 73.60, 35.33.HR-MS (ESI): *m*/*z* calcd for C~18~H~14~BrO~4~ (\[M + H\]^+^) 373.0070, found 373.0072.

*4-\[2-(3-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5d**) White crystals; mp: 189.7--190.4 °C; 45% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.34 (t, *J* = 1.6 Hz, 1H, Ar*H*), 8.14 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.91--7.76 (m, 1H, Ar*H*), 7.54--7.40 (m, 3H, Ar*H*), 7.36 (td, *J* = 7.6, 0.7 Hz, 1H, Ar*H*), 7.23 (dd, *J* = 8.0, 0.6 Hz, 1H, Ar*H*), 6.25 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.69 (dd, *J* = 8.3, 6.2 Hz, 1H, OC*H*), 5.65 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.33 (ddt, *J* = 17.4, 8.4, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.92 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.89, 163.60, 147.50, 137.07, 133.54, 133.12, 130.69, 130.42, 129.65, 128.77, 126.83, 126.42, 123.15, 77.32, 77.06, 76.81, 73.61, 35.20. HR-MS (ESI): *m*/*z* calcd for C~18~H~14~BrO~4~ (\[M + H\]^+^) 373.0070, found 373.0069.

*4-\[2-(4-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5e**) White crystals; mp: 184.7--185.2 °C; 53% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.05 (dd, *J* = 23.8, 8.5 Hz, 2H, Ar*H*), 7.70 (t, *J* = 11.9 Hz, 2H, Ar*H*), 7.56--7.20 (m, 4H, Ar*H*), 6.25 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.69 (dd, *J* = 8.3, 6.2 Hz, 1H, OC*H*), 5.63 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 3.32 (ddt, *J* = 17.4, 8.4, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.92 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.90, 164.22, 147.58, 133.55, 132.27, 131.65, 130.89, 130.62, 129.58, 127.66, 126.75, 126.44, 122.93, 77.27, 77.02, 76.76, 73.69, 35.16. HR-MS (ESI): *m*/*z* calcd for C~18~H~14~BrO~4~ (\[M + H\]^+^) 373.0070, found 373.0069.

*4-\[2-(4-Benzonitrile)phenyl\]-2-methylenebutyrolactone* (**5f**) Yellow oil; 65% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.31 (d, *J* = 8.5 Hz, 2H, Ar*H*), 7.86 (d, *J* = 8.5 Hz, 2H, Ar*H*), 7.55--7.43 (m, 2H, Ar*H*), 7.41--7.35 (m, 1H, Ar*H*), 7.30--7.24 (m, 1H, Ar*H*), 6.23 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.68 (t, *J* = 7.3 Hz, 1H, OC*H*), 5.64 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.33 (ddt, *J* = 17.4, 8.5, 2.5 Hz, 1H, C*H*HC=CH~2~), 3.02--2.93 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 163.38, 147.52, 133.47, 132.59, 130.68, 129.48, 127.05, 126.81, 23.12, 122.85, 120.68, 117.59, 115.82, 77.30, 77.04, 76.79, 75.28, 73.86, 35.02. HR-MS (ESI): *m*/*z* calcd for C~19~H~13~NNaO~4~ (\[M + Na\]^+^) 342.0736, found 342.0741.

*4-(2-Benzoyloxyphenyl)-2-methylenebutyrolactone* (**5g**) White solid; mp: 166.3--167.0 °C; 57% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.22 (d, *J* = 7.3 Hz, 2H, Ar*H*), 7.71 (t, *J* = 7.5 Hz, 1H, Ar*H*), 7.57 (t, *J* = 7.8 Hz, 2H, Ar*H*), 7.49 (t, *J* = 7.4 Hz, 1H, Ar*H*), 7.47--7.42 (m, 1H, Ar*H*), 7.35 (dd, *J* = 11.1, 4.0 Hz, 1H, Ar*H*), 7.25 (d, *J* = 8.1 Hz, 1H, Ar*H*), 6.24 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (dd, *J* = 8.2, 6.3 Hz, 1H, OC*H*), 5.63 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 3.34 (ddt, *J* = 17.4, 8.4, 2.5 Hz, 1H, CHHC=CH~2~), 2.92 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CHHC=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 133.76, 130.21, 128.64, 126.72, 122.12, 78.70, 77.28, 77.03, 76.77, 40.04, 36.41, 29.72, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~15~O~4~ (\[M + H\]^+^) 295.0964, found 295.0964.

*4-\[2-(2-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5h**) White crystals; mp: 172.8--173.4 °C; 47% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.21--8.12 (m, 1H, Ar*H*), 7.55--7.49 (m, 1H, Ar*H*), 7.49--7.39 (m, 2H, Ar*H*), 7.38--7.28 (m, 3H, Ar*H*), 7.26--7.19 (m, 1H, Ar*H*), 6.22 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.70 (dd, *J* = 8.3, 6.1 Hz, 1H, OC*H*), 5.61 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.32 (ddt, *J* = 17.4, 8.4, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.90 (ddt, *J* = 17.4, 5.9, 2.9 Hz, 1H, CH*H*C=CH~2~), 2.68 (s, 3H, ArC*H*~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.05, 165.29, 147.67, 141.92, 133.66, 133.33, 132.55, 131.16, 129.52, 127.60, 126.52, 126.17, 122.96, 77.40, 77.08, 76.77, 73.66, 35.30, 22.08.HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 337.0940.

*4-\[2-(3-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5i**) White crystals; mp: 179.3--179.9 °C; 45% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.99 (d, *J* = 8.7 Hz, 2H, Ar*H*), 7.48 (t, *J* = 8.0 Hz, 2H, Ar*H*), 7.45--7.39 (m, 2H, Ar*H*), 7.32 (t, *J* = 7.6 Hz, 1H, Ar*H*), 7.21 (d, *J* = 8.0 Hz, 1H, Ar*H*), 6.22 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.70 (dd, *J* = 8.3, 6.2 Hz, 1H, OC*H*), 5.60 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.31 (ddt, *J* = 17.4, 8.4, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.89 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CH*H*C=CH~2~), 2.46 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.06, 165.06, 147.69, 138.77, 134.93, 133.65, 132.48, 130.76, 129.52, 128.69, 127.36, 126.56, 126.16, 122.93, 77.30, 77.05, 76.79, 73.66, 35.28, 21.32. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 337.0940, found 337.0941.

*4-\[2-(4-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5j**) White crystals; mp: 181.2--181.6 °C; 46% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.08 (d, *J* = 8.2 Hz, 2H, Ar*H*), 7.49--7.38 (m, 2H, Ar*H*), 7.36--7.28 (m, 3H, Ar*H*), 7.24--7.19 (m, 1H, Ar*H*), 6.22 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.70 (dd, *J* = 8.3, 6.1 Hz, 1H, OC*H*), 5.60 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.31 (ddt, *J* = 17.4, 8.4, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.89 (ddt, *J* = 17.4, 5.9, 2.9 Hz, 1H, CH*H*C=CH~2~), 2.47 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.26, 163.06, 149.69,145.15, 138.77, 133.65, 132.49, 130.29, 129.53, 128.49, 126.51, 126.05, 122.95, 77.35, 77.03, 76.72, 73.71, 35.28, 21.83. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0937.

*4-\[2-(2-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5k**) White crystals; mp: 177.8--178.6 °C; 51% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.00 (dd, *J* = 7.7, 1.6 Hz, 1H, Ar*H*), 7.59 (td, *J* = 8.5, 1.7 Hz, 1H, Ar*H*), 7.41 (ddd, *J* = 15.7, 9.2, 4.6 Hz, 2H, Ar*H*), 7.33--7.19 (m, 2H, Ar*H*), 7.07 (dd, *J* = 12.2, 5.2 Hz, 2H, Ar*H*), 6.24 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.79 (dd, *J* = 8.2, 6.2 Hz, 1H, OC*H*), 5.61 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.95 (s, 3H, ArOC*H*~3~), 3.36 (ddt, *J* = 17.4, 8.3, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.87 (ddt, *J* = 17.4, 5.9, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.21, 164.40, 159.83, 147.61, 134.84, 133.89, 132.54, 129.32, 126.40, 125.81, 122.97, 122.72, 120.46, 118.38, 112.25, 77.31, 77.06, 76.80, 73.71, 56.01, 35.45. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0889.

*4-\[2-(3-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**5l**) White crystals; mp: 180.3--180.8 °C; 50% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.81 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.76--7.65 (m, 1H, Ar*H*), 7.55--7.40 (m, 3H, Ar*H*), 7.35 (t, *J* = 7.2 Hz, 1H, Ar*H*), 7.30--7.22 (m, 2H, Ar*H*), 6.25 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.72 (dd, *J* = 8.3, 6.2 Hz, 1H, OC*H*), 5.63 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 3.92 (s, 3H, ArOC*H*~3~), 3.42--3.22 (m, 1H, C*H*HC=CH~2~), 3.02--2.76 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.99, 164.76, 159.88, 147.70, 133.63, 132.44, 129.86, 129.54, 126.60, 126.24, 122.92, 122.56, 120.63, 114.65, 77.28, 77.02, 76.77, 73.69, 55.57, 35.24. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0889.

*4-\[2-(Butyryloxy)phenyl\]-2-methylenebutyrolactone* (**5m**) Colourless oil; 78% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.41--7.33 (m, 2H, Ar*H*), 7.30--7.21 (m, 1H, Ar*H*), 7.16--7.05 (m, 1H, Ar*H*), 6.31 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.68 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.61 (dd, *J* = 8.3, 6.3 Hz, 1H, OC*H*), 3.34 (ddt, *J* = 17.4, 8.4, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.86 (ddt, *J* = 17.4, 5.9, 2.8 Hz, 1H, CH*H*C=CH~2~), 2.61--2.50 (m, 2H, CH~3~CH~2~CH~2~), 1.78 (dt, *J* = 14.8, 7.4 Hz, 2H, CH~3~CH~2~CH~2~), 1.05 (dd, *J* = 9.0, 5.9 Hz, 3H, CH~3~CH~2~CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 171.75, 147.64, 133.87, 131.95, 129.47, 126.31, 77.34, 77.08, 76.83, 73.94, 36.12, 35.23, 18.41, 13.68. HR-MS (ESI): *m*/*z* calcd for C~15~H~16~NaO~4~ (\[M + Na\]^+^) 283.0840, found 283.0841.

*4-\[2-(Cinnamoyloxy)phenyl\]-2-methylenebutyrolactone* (**5n**) Yellow oil; 48% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.84 (d, *J* = 15.9 Hz, 1H, Ar*H*), 7.49--7.39 (m, 2H, Ar*H*), 7.32 (t, *J* = 7.5 Hz, 1H, Ar*H*), 7.29 (s, 1H, Ar*H*), 7.24--7.17 (m, 2H, Ar*H*), 7.01--6.97 (m, 1H, Ar*H*), 6.48 (d, *J* = 15.9 Hz, 1H, Ar*H*), 6.30 (t, *J* = 2.7 Hz, 1H, C=C*H*H), 5.71 (dd, *J* = 8.2, 6.4 Hz, 1H, OC*H*), 5.66 (d, *J* = 7.3 Hz, 1H, C=CH*H*), 4.00 (s, 2H, CH=CH), 3.39 (dd, *J* = 17.5, 8.5 Hz, 1H, C*H*HC=CH~2~), 2.99--2.84 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 148.74, 147.72, 129.49, 127.04, 126.21, 123.67, 122.95, 122.72, 114.93, 113.54, 109.70, 77.27, 77.01, 76.76, 74.01, 56.04, 35.16, 26.33. HR-MS (ESI): *m*/*z* calcd for C~21~H~19~O~6~ (\[M + H\]^+^) 367.1173, found 317.1176.

*4-\[3-(3-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6a**) White solid; mp: 205.7--206.4 °C; 52% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.20 (s, 1H, Ar*H*), 8.10 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.65 (dd, *J* = 8.0, 1.0 Hz, 1H, Ar*H*), 7.55--7.45 (m, 2H, Ar*H*), 7.30--7.19 (m, 3H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.74 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.62--5.54 (m, 1H, OC*H*), 3.52--3.41 (m, 1H, C*H*HC=CH~2~), 2.97 (ddt, *J* = 12.2, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 163.87, 151.10, 141.83, 134.86, 133.76, 131.04, 130.35, 129.90, 128.31, 122.93, 121.78, 118.66, 77.41, 76.88, 76.76, 36.21, 29.70. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~ClNaO~4~ (\[M + Na\]^+^) 351.0394, found 351.0395.

*4-\[3-(4-Chlorobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6b**) White solid; mp: 209.8--210.5 °C; 64% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.22--8.03 (m, 2H, Ar*H*), 7.61--7.36 (m, 3H, Ar*H*), 7.33--7.14 (m, 3H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.56 (dd, *J* = 7.8, 6.7 Hz, 1H, OC*H*), 3.44 (ddt, *J* = 17.1, 8.1, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.94 (ddt, *J* = 17.1, 6.2, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 164.24, 151.14, 141.80, 140.37, 133.73, 131.58, 130.12, 129.05, 127.72, 122.93, 121.85, 118.72, 77.52 ,76.91, 76.74, 36.21. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~ClNaO~4~ (\[M + Na\]^+^) 351.0394, found 351.0394.

*4-\[3-(2-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6c**) White crystals; mp: 175.3--175.8 °C; 56% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.06 (dd, *J* = 7.6, 1.7 Hz, 1H, Ar*H*), 7.83--7.72 (m, 1H, Ar*H*), 7.61--7.42 (m, 2H, Ar*H*), 7.30 (d, *J* = 10.2 Hz, 4H, Ar*H*), 6.38 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.76 (dd, *J* = 6.3, 3.9 Hz, 1H, C=CH*H*), 5.67--5.40 (m, 1H, OC*H*), 3.62--3.30 (m, 1H, C*H*HC=CH~2~), 3.05--2.88 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 134.74, 133.35, 130.12, 127.40, 126.70, 122.91, 118.69, 77.28, 77.02, 76.77, 36.35, 29.71, 19.20. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9889, found 394.9892.

*4-\[3-(3-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6d**) White crystals; mp: 178.6--178.9 °C; 63% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.31 (d, *J* = 52.5 Hz, 1H, Ar*H*), 8.10 (dd, *J* = 52.3, 7.5 Hz, 1H, Ar*H*), 7.84--7.72 (m, 1H, Ar*H*), 7.54--7.34 (m, 2H, Ar*H*), 7.33--7.17 (m, 3H, Ar*H*), 6.36 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.74 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.66--5.46 (m, 1H, OC*H*), 3.60--3.36 (m, 1H, C*H*HC=CH~2~), 2.97 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 136.72, 133.14, 132.05, 131.69, 130.17, 128.76, 126.91, 126.53, 122.94, 121.78, 118.66, 77.37, 76.87, 76.76, 36.21, 29.72, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9894, found 394.9890.

*4-\[3-(4-Bromobenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6e**) White crystals; mp: 168.6--169.4 °C; 41% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.10 (d, *J* = 8.5 Hz, 2H, Ar*H*), 8.00 (d, *J* = 8.4 Hz, 2H, Ar*H*), 7.69 (dd, *J* = 24.8, 8.4 Hz, 4H, Ar*H*), 6.37 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.76 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.61 (s, 1H, OC*H*), 4.35 (t, *J* = 6.8 Hz, 1H, C*H*HC=CH~2~), 3.48 (dd, *J* = 17.0, 8.1 Hz, 1H, CH*H*C=CH~2~). ^13^C-NMR (125 MHz, CDCl~3~): δ 150.78, 137.95, 133.05, 131.69, 129.05, 127.28, 126.76, 122.75, 122.08, 78.62, 77.28, 77.03, 76.78, 40.03, 36.36, 15.00. HR-MS (ESI): *m*/*z* calcd for C~18~H~13~BrNaO~4~ (\[M + Na\]^+^) 394.9890, found 394.9889.

*4-(3-Benzoyloxyphenyl)-2-methylenebutyrolactone* (**6f**) White solid; mp: 204.5--204.8 °C; 52% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.22 (d, *J* = 7.3 Hz, 2H, Ar*H*), 7.68 (t, *J* = 7.5 Hz, 1H, Ar*H*), 7.49 (t, *J* = 7.8 Hz, 1H, Ar*H*), 7.32--7.20 (m, 5H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.62--5.52 (m, 1H, OC*H*), 3.46 (ddt, *J* = 17.1, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.98 (ddt, *J* = 9.2, 6.0, 2.8 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 135.76, 131.21, 128.69, 126.77, 122.62, 78.70, 77.28, 77.03, 76.77, 42.04, 36.51, 29.79, 15.20. HR-MS (ESI): *m*/*z* calcd for C~18~H~14~NaO~4~ (\[M + Na\]^+^) 317.0785, found 317.0784.

*4-\[3-(2-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6g**) White crystals; mp: 178.3--178.9 °C; 57% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.18 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.54--7.46 (m, 2H, Ar*H*), 7.36 (t, *J* = 7.7 Hz, 2H, Ar*H*), 7.24 (dd, *J* = 13.8, 7.7 Hz, 3H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.64--5.51 (m, 1H, OC*H*), 3.46 (ddt, *J* = 17.1, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.98 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~), 2.70 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 165.62, 151.30, 141.68, 141.44, 133.81, 132.91, 132.02, 131.21, 130.02, 128.21, 125.98, 122.71, 122.06, 118.92, 77.26, 77.01, 76.76, 36.23, 21.96. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0940.

*4-\[3-(3-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6h**) White crystals; mp: 177.6--178.2 °C; 68% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.03 (s, 1H, Ar*H*), 7.46 (ddd, *J* = 15.1, 9.9, 5.9 Hz, 3H, Ar*H*), 7.28 (d, *J* = 9.6 Hz, 4H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.66--5.52 (m, 1H, OC*H*), 3.50--3.39 (m, 1H, C*H*HC=CH~2~), 3.03--2.93 (m, 1H, CH*H*C=CH~2~), 2.48 (s, 3H, ArCH~3~); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.05, 165.28, 152.07, 136.51, 137.36, 134.45, 134.61, 130.71, 129.69, 128.53, 127.37, 126.67, 122.26, 77.48, 77.28, 77.02, 76.77, 36.32, 21.30. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0942, found 331.0940.

*4-\[3-(4-Methylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6i**) White crystals; mp: 168.5--168.9 °C; 57% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.10 (d, *J* = 8.1 Hz, 2H, Ar*H*), 7.48 (t, *J* = 7.8 Hz, 1H, Ar*H*), 7.34 (d, *J* = 8.0 Hz, 1H, Ar*H*), 7.30--7.20 (m, 4H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.70--5.40 (m, 1H, OC*H*), 3.56--3.36 (m, 1H, C*H*HC=CH~2~), 2.98 (ddt, *J* = 17.1, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~), 2.34 (d, *J* = 144.3 Hz, 3H, ArCH~3~). ^13^C-NMR (125 MHz, CDCl~3~): δ 169.99, 165.13, 151.11, 144.66, 141.64, 130.24, 130.01, 129.36, 127.37, 126.58, 122.79, 122.63, 122.00, 118.87, 77.27, 77.01, 76.76, 36.22, 21.77. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~4~ (\[M + Na\]^+^) 331.0940, found 331.0941.

*4-\[3-(2-Methoxylbenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6j**) White crystals; mp: 172.3--172.8 °C; 45% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.07--7.99 (m, 1H, Ar*H*), 7.61--7.56 (m, 1H, Ar*H*), 7.32--7.20 (m, 4H, Ar*H*), 7.08 (t, *J* = 7.6 Hz, 2H, Ar*H*), 6.34 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.62--5.43 (m, 1H, OC*H*), 3.97 (s, 3H, ArOC*H*~3~), 3.47--3.38 (m, 1H, C*H*HC=CH~2~), 2.97 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~). ^13^C-NMR (125 MHz, CDCl~3~): δ 151.37, 141.52, 134.54, 133.87, 132.27, 129.92, 122.76, 122.54, 122.09, 120.27, 118.98, 112.26, 77.30, 77.02, 76.76, 56.07, 49.16, 36.23, 33.95, 25.63, 24.94. HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0890.

*4-\[3-(3-Methoxybenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6k**) White crystals; mp: 183.7--184.2 °C; 57% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.82 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.73 (d, *J* = 7.7 Hz, 1H, Ar*H*), 7.47 (dt, *J* = 18.6, 7.8 Hz, 2H, Ar*H*), 7.31--7.19 (m, 4H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.62--5.55 (m, 1H, OC*H*), 3.92 (s, 3H, ArOC*H*~3~), 3.46 (ddt, *J* = 17.0, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 3.01--2.91 (m, 1H, CH*H*C=CH~2~). ^13^C-NMR (125 MHz, CDCl~3~): δ 159.75, 151.34, 141.70, 133.78, 130.05, 129.67, 129.49, 122.95--122.49, 121.94, 120.39, 118.80, 114.51, 77.27, 77.01, 76.76, 55.49, 36.21, 29.70.HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0889.

*4-\[3-(4-Methoxybenzoyloxy)phenyl\]-2-methylenebutyrolactone* (**6l**) White crystals; mp: 182.6--183.3 °C; 56% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 8.23--8.07 (m, 2H, Ar*H*), 7.45 (t, *J* = 8.0 Hz, 1H, Ar*H*), 7.29--7.14 (m, 3H, Ar*H*), 7.02--6.92 (m, 2H, Ar*H*), 6.32 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.70 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.55 (dd, *J* = 7.8, 6.8 Hz, 1H, OC*H*), 3.90 (s, 3H, ArOC*H*~3~), 3.43 (ddt, *J* = 17.1, 8.1, 2.5 Hz, 1H, C*H*HC=CH~2~), 3.00--2.87 (m, 1H, CH*H*C=CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 169.99, 164.80, 164.06, 151.44, 141.61, 133.83, 132.35, 130.00, 122.84, 122.60, 122.06, 121.52, 118.92, 113.93, 77.35, 77.06, 76.74, 55.56, 36.21.HR-MS (ESI): *m*/*z* calcd for C~19~H~16~NaO~5~ (\[M + Na\]^+^) 347.0889, found 347.0892.

*4-(3-Propionyloxyphenyl)-2-methylenebutyrolactone* (**6m**) Colourless oil; 56% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.42 (t, *J* = 8.3 Hz, 1H, Ar*H*), 7.29 (s, 1H, Ar*H*), 7.20 (d, *J* = 7.8 Hz, 1H, Ar*H*), 7.09 (s, 1H, Ar*H*), 6.34 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.72 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.64--5.43 (m, 1H, OC*H*), 3.44 (ddt, *J* = 17.1, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.94 (ddt, *J* = 17.1, 6.0, 2.8 Hz, 1H, CH*H*C=CH~2~), 2.62 (q, *J* = 7.5 Hz, 2H, CH~3~CH~2~), 1.29 (t, *J* = 7.5 Hz, 3H, CH~3~CH~2~); ^13^C-NMR (125 MHz, CDCl~3~): δ 172.81, 151.14, 141.57, 133.78, 129.92, 122.78, 122.53, 121.75, 118.63, 77.23, 77.01, 76.75, 36.20, 27.73, 9.02. HR-MS (ESI): *m*/*z* calcd for C~14~H~14~NaO~4~ (\[M + Na\]^+^) 269.0784, found 269.0784.

*4-(3-Cinnamoyloxyphenyl)-2-methylenebutyrolactone* (**6n**) Yellow oil; 34% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.87 (d, *J* = 16.0 Hz, 1H, Ar*H*), 7.64--7.55 (m, 2H, CH=CH), 7.47--7.38 (m, 4H, Ar*H*), 7.25--7.10 (m, 3H, Ar*H*), 6.62 (d, *J* = 16.0 Hz, 1H, Ar*H*), 6.31 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.70 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 5.60--5.45 (m, 1H, OC*H*), 3.42 (ddt, *J* = 17.1, 8.1, 2.5 Hz, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 17.1, 6.0, 2.9 Hz, 1H, CH*H*C=CH~2~); ^13^C-NMR (100 MHz, CDCl~3~): δ 169.99, 165.26, 151.17, 147.00, 141.64, 134.07, 133.83, 130.88, 130.01, 129.06, 128.38, 122.76, 121.88, 118.76, 116.98, 77.56,76.95, 76.78, 36.19. HR-MS (ESI): *m*/*z* calcd for C~20~H~16~NaO~4~ (\[M + Na\]^+^) 343.0940, found 343.0941.

### 3.2.3. General Synthetic Procedure for Ether Compounds {#sec3dot2dot3-molecules-21-00130}

K~2~CO~3~ (13.8 mg, 10.0 mmol) and Cs~2~CO~3~ (3.2 mg, 1.0 mmol) as catalyst, intermediate compounds **5** or **6** (196.0 mg, 1.1 mmol), and acetonitrile (35.0 mL) were added into a round bottomed flask and refluxed at 78 °C. Then, the appropriate brominated alkane (1.2 mmol) was slowly added into the mixture and stirred for 12 h at 78 °C. The progress of the reaction was monitored by TLC. After complete conversion, the suspension was filtered and washed with acetonitrile. Finally, the solution was dried with anhydrous Na~2~SO~4~, filtered, and evaporated under vacuum. The obtained crude products were also purified by column chromatography. The ^1^H-NMR, ^13^C-NMR, and HR-ESI-MS data are listed below.

*4-(2-Butoxyphenyl)-2-methylenebutyrolactone* (**5o**) Yellow oil; 42% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.38--7.30 (m, 2H, Ar*H*), 7.04--6.89 (m, 2H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.77 (dd, *J* = 8.4, 6.0 Hz, 1H, OC*H*), 5.67 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 4.13--3.95 (m, 2H, CH~3~CH~2~CH~2~CH~2~O), 3.45 (ddt, *J* = 17.4, 8.5, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.92 (ddt, *J* = 17.4, 5.7, 2.8 Hz, 1H, CH*H*C=CH~2~), 1.86--1.76 (m, 2H, CH~3~CH~2~CH~2~CH~2~O), 1.57--1.47 (m, 2H, CH~3~CH~2~CH~2~CH~2~O), 1.05--0.98 (m, 3H, CH~3~CH~2~CH~2~CH~2~O); ^13^C-NMR (100 MHz, CDCl~3~): δ 155.78, 134.92, 129.42, 126.12, 121.82, 120.40, 111.27, 77.29, 76.78, 75.21, 67.79, 35.04, 31.28, 30.92, 19.41, 13.83. HR-MS (ESI): *m*/*z* calcd for C~15~H~18~NaO~3~ (\[M + Na\]^+^) 269.1148, found 269.1147.

*4-(2-Propoxylphenyl)-2-methylenebutyrolactone* (**5p**) Yellow oil; 38% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.30 (dd, *J* = 13.1, 5.4 Hz, 1H, Ar*H*), 6.90 (dd, *J* = 12.5, 10.8 Hz, 3H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.58--5.41 (m, 1H, OC*H*), 3.94 (t, *J* = 6.5 Hz, 2H, CH~3~CH~2~CH~2~O), 3.41 (ddt, *J* = 17.1, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~), 1.90--1.78 (m, 2H, CH~3~CH~2~CH~2~O), 1.12--0.97 (m, 3H, CH~3~CH~2~CH~2~O); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.14, 159.58, 141.41, 134.20, 129.93, 122.43, 117.30, 114.49, 111.51, 77.82, 77.28, 77.03, 76.77, 69.61, 22.57, 10.51. HR-MS (ESI): *m*/*z* calcd for C~14~H~16~NaO~3~ (\[M + Na\]^+^) 255.0991, found 255.0992.

*4-(2-Isopropoxylphenyl)-2-methylenebutyrolactone* (**5q**) Yellow oil; 47% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.33 (dd, *J* = 12.7, 6.6 Hz, 2H, Ar*H*), 6.96 (dt, *J* = 12.8, 5.9 Hz, 2H, Ar*H*), 6.32 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.73 (dd, *J* = 8.4, 5.9 Hz, 1H, OC*H*), 5.67 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 4.67 (dt, *J* = 12.1, 6.0 Hz, 1H, (CH~3~)~2~CHO), 3.45 (ddt, *J* = 17.4, 8.5, 2.6 Hz, 1H, C*H*HC=CH~2~), 2.91 (ddt, *J* = 17.5, 5.7, 2.8 Hz, 1H, CH*H*C=CH~2~), 1.38 (dd, *J* = 8.8, 6.1 Hz, 6H, (CH~3~)~2~CHO); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.74, 154.58, 135.17, 129.35, 129.06, 126.55, 121.63, 120.19, 112.42, 77.29, 77.04, 76.78, 75.52, 69.95, 34.95, 29.72, 22.01. HR-MS (ESI): *m*/*z* calcd for C~14~H~16~NaO~3~ (\[M + Na\]^+^) 255.0991, found 255.0990.

*4-(2-Ethoxyphenyl)-2-methylenebutyrolactone* (**5r**) Yellow oil; 46% yield; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.31--7.25 (m, 3H, Ar*H*), 6.95 (td, *J* = 7.5, 0.8 Hz, 1H, Ar*H*), 6.28 (t, *J* = 2.9 Hz, 1H, C=C*H*H), 5.71 (dd, *J* = 8.5, 5.8 Hz, 1H, OC*H*), 5.63 (t, *J* = 2.5 Hz, 1H, C=CH*H*), 4.06 (qd, *J* = 7.0, 2.6 Hz, 2H, CH~3~CH~2~O), 3.42 (dd, *J* = 17.4, 8.5 Hz, 1H, C*H*HC=CH~2~), 2.95--2.77 (m, 1H, CH*H*C=CH~2~), 1.40 (t, *J* = 7.0 Hz, 3H, CH~3~CH~2~O).^13^C-NMR (125 MHz, CDCl~3~): δ 129.48, 126.34, 121.70, 120.42, 111.34, 77.29, 77.03, 76.71, 75.44, 63.64, 34.90, 14.73. HR-MS (ESI): *m*/*z* calcd for C~13~H~14~NaO~3~ (\[M + Na\]^+^) 241.0835, found 241.0834.

*4-(3-Butoxyphenyl)-2-methylenebutyrolactone* (**6o**) Yellow oil; 47% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.32 (dd, *J* = 13.2, 5.4 Hz, 2H, Ar*H*), 6.91 (d, *J* = 9.0 Hz, 2H, Ar*H*), 6.35 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.73 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.63--5.40 (m, 1H, OC*H*), 4.01 (t, *J* = 6.5 Hz, 2H, CH~3~CH~2~ CH~2~CH~2~O), 3.43 (ddt, *J* = 17.0, 8.0, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.95 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~), 1.86--1.74 (m, 2H, CH~3~CH~2~CH~2~CH~2~O), 1.58--1.47 (m, 2H, CH~3~CH~2~CH~2~CH~2~O), 1.09--0.96 (m, 3H, CH~3~CH~2~CH~2~CH~2~O); ^13^C-NMR (100 MHz, CDCl~3~): δ 155.78, 134.92, 129.42, 126.12, 121.82, 120.40, 111.27, 77.29, 76.78, 75.21, 67.79, 35.04, 31.28, 30.92, 19.41, 13.83. HR-MS (ESI): *m*/*z* calcd for C~15~H~18~NaO~3~ (\[M + Na\]^+^) 269.1148, found 269.1147.

*4-(3-Propoxylphenyl)-2-methylenebutyrolactone* (**6p**) Yellow oil; 54% yield; ^1^H-NMR (500 MHz, CDCl~3~): δ 7.30 (dd, *J* = 13.1, 5.4 Hz, 1H, Ar*H*), 6.90 (dd, *J* = 12.5, 10.8 Hz, 3H, Ar*H*), 6.33 (t, *J* = 2.8 Hz, 1H, C=C*H*H), 5.71 (t, *J* = 2.4 Hz, 1H, C=CH*H*), 5.58--5.41 (m, 1H, OC*H*), 3.94 (t, *J* = 6.5 Hz, 2H, CH~3~CH~2~CH~2~O), 3.41 (ddt, *J* = 17.1, 8.1, 2.4 Hz, 1H, C*H*HC=CH~2~), 2.93 (ddt, *J* = 17.1, 6.1, 2.9 Hz, 1H, CH*H*C=CH~2~), 1.90--1.78 (m, 2H, CH~3~CH~2~CH~2~O), 1.12--0.97 (m, 3H, CH~3~CH~2~CH~2~O); ^13^C-NMR (125 MHz, CDCl~3~): δ 170.14, 159.58, 141.41, 134.20, 129.93, 122.43, 117.30, 114.49, 111.51, 77.82, 77.28, 77.03, 76.77, 69.61, 22.57, 10.51. HR-MS (ESI): *m*/*z* calcd for C~14~H~16~NaO~3~ (\[M + Na\]^+^) 255.0991, found 255.0992.

3.3. Fungicidal Activity Bioassay {#sec3dot3-molecules-21-00130}
---------------------------------

### 3.3.1. Preparation of Spore Suspension {#sec3dot3dot1-molecules-21-00130}

The fungal pathogens *C. lagenarium* and *B. cinerea* was provided by the Agricultural Culture Collection of China (Yangling, Shaanxi, China). *C. lagenarium* was cultured for 2 weeks at 25 ± 1 °C on potato dextrose agar (PDA) while *B. cinerea* was cultured at 20 °C on the same medium after being retrieved from the storage tube. Plates were flooded with sterile distilled water, and then conidia were scraped with a glass rod. Mycelial debris was removed by filtration. The spores were harvested and suspended in sterile distilled water containing 0.1% (*v*/*v*) Tween 20. The concentration of the spore suspension was adjusted to 1.0 × 10^6^ spores/mL with sterilized distilled water following \[[@B21-molecules-21-00130],[@B39-molecules-21-00130]\].

### 3.3.2. Spore Germination Assay {#sec3dot3dot2-molecules-21-00130}

The tested samples (10.0 mg) dissolved in acetone (0.1 mL) were diluted with sterile distilled water to prepare 10.0 mL stock solution, which was further diluted to prepare test solutions in which the final concentration of acetone was \<1% (*v*/*v*). A series of concentrations of tested samples and one control (1% acetone with sterile distilled water) were separately tested for spore germination of *C. lagenarium* or *B. cinerea*. The samples were inoculated with spore suspension of *C. lagenarium* or *B. cinerea* containing 1.0 × 10^6^ spores/mL. Aliquots of 10 μL of prepared spore suspension were placed on separate glass slides in triplicate. Slides containing the spores were incubated in a moisture chamber at 25 °C for 6\~8 h. Each slide was then observed under the microscope for spore germination. Spores were considered to have germinated if the length of the germ tube was at least half the length of the spore. Afterward, spore germination was stopped by applying a drop of lactophenol-cotton blue to the inoculation sites on plates. The numbers of generated spores were counted under a microscope (Olympus BX61, Tokyo, Japan), and the percentage of germinated spores was calculated. Chlorothalonil was used as the positive control \[[@B21-molecules-21-00130],[@B39-molecules-21-00130]\].

3.4. Building and Validation of the QSAR Model {#sec3dot4-molecules-21-00130}
----------------------------------------------

Firstly, the optimal conformers of the title compounds with the lowest energy were computed at the DFT/6-31G (d) level using the Gaussian 03W package of programs \[[@B40-molecules-21-00130]\]. Then, the calculated results were changed into a form compatible with CODESSA 2.7.15 using Ampac 9.1.3 \[[@B41-molecules-21-00130],[@B42-molecules-21-00130]\]. Finally, all of the molecular descriptors involved in these compounds were calculated by CODESSA 2.7.15. In order to find out which structural features play an important role in the fungicidal activity against *C. lagenarium*, the heuristic method analysis was selected to generate the QSAR model. In this model, the statistical criteria were indicated by the squared correction coefficient (*R*^2^), the squared standard error of the estimates (*S*^2^), and the Fisher significance ratio (*F*). The tested IC~50~ values were converted into the corresponding log IC~50~ values and used as dependent variables in the QSAR studies. The quality of the final model was determined using both an internal validation and the "leave-one-out" cross-validation methods \[[@B43-molecules-21-00130]\].

4. Conclusions {#sec4-molecules-21-00130}
==============

In summary, forty-six ester and six ether derivatives containing α-methylene-γ-butyrolactone moieties were synthesized, and their fungicidal activities against *C. lagenarium* and *B. cinerea* was investigated. Halogen atom-containing derivatives showed better activity than others, especially compounds **6a**,**d** which exhibited excellent fungicidal activity against *C. lagenarium*. Both SAR and QSAR studies indicated that the structural characteristics had an important influence on the fungicidal activity, and electron withdrawing substituents on the α-methylene-γ-butyrolactone derivatives had a positive effect on the fungicidal activity. It was notable that the present set of compounds consisted of racemic mixtures; it will be an interesting task for further studies to test the most active compounds in optically pure form. The level of fungicidal activity and cytotoxic activity observed with α-methylene-γ-butyrolactone derivatives provide great impetus for further work on the design of high-activity and non-toxic crop-protection agents.
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